NCT03042429View on ClinicalTrials.gov

Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

January 1, 2007

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Neuroblastoma
Interventions
DRUG

Cycles N8, N5 and N6

two chemotherapy cycles N8 followed by standard arm therapy

DRUG

Cycles N5 and N6

Standard arm six chemotherapy cycles (3xN5 and 3x N6) followed by myeloablative therapy with stem cell support and isotretinoin

Trial Locations (1)

50924

University of Cologne, Cologne

All Listed Sponsors
lead

University of Cologne

OTHER

NCT03042429 - Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients | Biotech Hunter | Biotech Hunter